Asper Biotech has updated its Ashkenazi Jewish Diseases Test to include mutations in the BRCA1, BRCA2, and LCA5 genes that are common in the Ashkenazi Jewish population. Asper's test now detects up to 112 variants in 27 genes.
Asper Biotech recently introduced a number of new test panels targeted to mitochondrial diseases.
Asper Biotech recently launched a new carrier test to detect the most common mutations associated with autosomal recessive disorders that are overrepresented in the Hutterite population.
From its office in Tartu, Estonia, Asper Biotech continues to introduce new microarray-based tests related to reproductive health, oncology, and opthamalogy.
Asper Biotech recently launched a test for Leber hereditary optic neuropathy, or LHON, a disease characterized by optic nerve dysfunction that leads to painless, subacute loss of central vision.
Asper Biotech recently launched several new reprogenetic tests. The Tartu, Estonia-based firm uses arrayed primer extension to test fetal cells for specific genetic abnormalities.
By Justin PetroneThis story was originally posted Sept. 10
Asper Biotech has introduced array-based prenatal testing for fetuses with increased nuchal translucency but normal karyotype.
Ambry Genetics last week launched its CancerArray, an exon-focused, 180,000-probe array for comparative genomic hybridization.
Asper Biotech's Sensorineural Hearing Loss Test, Fujifilm's DMP-5005 Materials Printer, BioForce Nanosciences' ProCleaner Plus
Anagnostics' Hyborg System, Asper Biotech's Congenital Stationary Night Blindness Genetic Test
The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.
Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.
In Science this week: in vitro generation of human reproductive cells, and more.
Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.